Literature DB >> 15883340

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

S J Tabrizi1, A M Blamire, D N Manners, B Rajagopalan, P Styles, A H V Schapira, T T Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15883340     DOI： 10.1212/01.WNL.0000160388.96242.77

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  19 in total

Review 1.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 2.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 3.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

4.  A Prophylactic Role for Creatine in Hypoxia?

Authors:  Elisabeth Engl; Mona M Garvert
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

Review 5.  [Huntington's disease].

Authors:  J D Rollnik
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

6.  Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

Authors:  Clare E Turner; Winston D Byblow; Nicholas Gant
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 7.  Mitochondrial matters of the brain: the role in Huntington's disease.

Authors:  C Turner; A H V Schapira
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

8.  Early alterations of brain cellular energy homeostasis in Huntington disease models.

Authors:  Fanny Mochel; Brandon Durant; Xingli Meng; James O'Callaghan; Hua Yu; Emmanuel Brouillet; Vanessa C Wheeler; Sandrine Humbert; Raphael Schiffmann; Alexandra Durr
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 9.  Novel therapeutic strategies in Parkinson's disease.

Authors:  Peter Klivenyi; Laszlo Vecsei
Journal:  Eur J Clin Pharmacol       Date:  2009-10-16       Impact factor: 2.953

10.  Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Authors:  William Lin; Un Jung Kang
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.